Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details 3)

v3.8.0.1
Stockholders' Equity (Details 3) - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2017
Dec. 31, 2016
Stockholders Equity Details 3    
Non-vested Shares at beginning of period 450,476 359,001
Shares Granted 31,425 1,210,467
Shares Vested (68,951) (1,118,992)
Shares Forfeited
Non-vested Shares at end of period 412,950 450,476
Weighted average fair value grant date, beginning of period $ 3.60 $ 4.55
Weighted average fair value grant date, granted 0.81 1.71
Weighted average fair value grant date, vested 5.89 1.81
Weighted average fair value grant date, forfeited
Weighted average fair value grant date, end of period 3.00 3.60
Weighted average exercise price, beginning of period 5.40 6.70
Weighted average exercise price, granted 1.08 3.02
Weighted average exercise price, vested 8.82 3.19
Weighted average exercise price, forfeited
Weighted average exercise price, end of period $ 4.51 $ 5.40